Studies have shown that the PTEN gene is inactivated in a variety of malignant tumors (such as bladder cancer, prostate cancer, endometrial cancer and gastric cancer) due to deletion, mutation, or reduced transcription [13–16]. Here, PTEN is linked to urinary bladder carcinoma.